{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:42:11Z","timestamp":1770885731596,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clinre.2018.08.008","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T02:28:36Z","timestamp":1536805716000},"page":"67-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated lactate impairs the efficacy of antiviral treatment on post-hepatectomy survival for advanced stage hepatitis B virus\u2009\u2013\u2009related hepatocellular carcinoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Jianping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songshan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2018.08.008_bib0005","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2018.08.008_bib0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00534-011-0489-z","article-title":"Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma","volume":"19","author":"Urata","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.clinre.2018.08.008_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","article-title":"Resection and liver transplantation for hepatocellular carcinoma","volume":"25","author":"Ilovet","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2018.08.008_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2018.08.008_bib0025","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.08.008_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.08.008_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.11.007","article-title":"Efficacy of entecavir in treatment-na\u00efve patients with hepatitis B virus-related decompensated cirrhosis","volume":"52","author":"Shim","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2011.09.018","article-title":"Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study","volume":"56","author":"Petersen","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0045","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2013.51.8381","article-title":"Recurrent hepatocellular carcinoma: it's the virus!","volume":"31","author":"Kim","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archsurg.2011.125","article-title":"Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma","volume":"146","author":"Chan","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.clinre.2018.08.008_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.asjsur.2016.03.001","article-title":"Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC stage B\/C","volume":"40","author":"Wei","year":"2017","journal-title":"Asian J Surg"},{"key":"10.1016\/j.clinre.2018.08.008_bib0060","first-page":"158","article-title":"Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy","volume":"10","author":"Ke","year":"2013","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.clinre.2018.08.008_bib0065","first-page":"1647","article-title":"Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort","volume":"35","author":"Sakamoto","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clinre.2018.08.008_bib0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jgh.12499","article-title":"Extra-hepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment","volume":"29","author":"Fung","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.13659","article-title":"Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients","volume":"44","author":"Lampertico","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2018.08.008_bib0080","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/MCG.0b013e31819c3945","article-title":"Fatal lactic acidosis associated with the use of combination oral medications to treat reactivation of hepatitis B","volume":"43","author":"Cohen","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0085","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23346","article-title":"Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function","volume":"50","author":"Lange","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.08.008_bib0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2018.08.008_bib0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7150\/jca.14274","article-title":"Warburg effect\u2009\u2013\u2009a consequence or the cause of carcinogenesis?","volume":"7","author":"Devic","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.clinre.2018.08.008_bib0100","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2018.08.008_bib0105","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jss.2013.04.056","article-title":"Changes in blood lactate levels after major elective abdominal surgery and the association with outcomes: a prospective observational study","volume":"184","author":"Li","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.clinre.2018.08.008_bib0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jhbp.87","article-title":"Highest intraoperative lactate level could predict post-operative infectious complications after hepatectomy, reflecting the Pringle maneuver especially in chronic liver disease","volume":"21","author":"Meguro","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.clinre.2018.08.008_bib0115","first-page":"405","article-title":"[The guideline of prevention and treatment for chronic hepatitis B (2010 version)]","volume":"32","year":"2011","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.clinre.2018.08.008_bib0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"Lai","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.08.008_bib0125","doi-asserted-by":"crossref","first-page":"e102761","DOI":"10.1371\/journal.pone.0102761","article-title":"Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2018.08.008_bib0130","doi-asserted-by":"crossref","first-page":"e66457","DOI":"10.1371\/journal.pone.0066457","article-title":"The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by antiviral therapy","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2018.08.008_bib0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/apt.13034","article-title":"Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study","volume":"41","author":"Chong","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2018.08.008_bib0140","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1245\/s10434-013-3320-z","article-title":"Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?","volume":"21","author":"Yu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0145","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.3748\/wjg.v19.i33.5575","article-title":"Lactic acidosis during telbivudine treatment for HBV: a case report and literature review","volume":"19","author":"Jin","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2018.08.008_bib0150","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.dld.2011.06.013","article-title":"Lactic acidosis during entecavir treatment in decompensated hepatitis B virus-related cirrhosis","volume":"43","author":"Marzano","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2018.08.008_bib0155","first-page":"165","article-title":"Lactic acidosis during entecavir antiviral treatment in a patient with hepatitis B virus-related decompensated cirrhosis","volume":"64","author":"Mao","year":"2015","journal-title":"West Indian Med J"},{"key":"10.1016\/j.clinre.2018.08.008_bib0160","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2018.08.008_bib0165","doi-asserted-by":"crossref","first-page":"E440","DOI":"10.21037\/jtd.2016.03.80","article-title":"Lactate: the Black Peter in high-risk gastro-intestinal surgery patients","volume":"8","author":"Honore","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.clinre.2018.08.008_bib0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00002018-200023060-00001","article-title":"Toxicity of anti-retroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?","volume":"23","author":"Moyle","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinre.2018.08.008_bib0175","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1007\/s00268-017-4118-0","article-title":"Elevated lactate is independently associated with adverse outcomes following hepatectomy","volume":"41","author":"Lemke","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.clinre.2018.08.008_bib0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/SLA.0000000000001468","article-title":"Arterial lactate concentration at the end of an elective hepatectomy is an early predictor of the post-operative course and a potential surrogate of intraoperative events","volume":"262","author":"Vibert","year":"2015","journal-title":"Ann Surg"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:55Z","timestamp":1761895615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740118301724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2210740118301724"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2018.08.008","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated lactate impairs the efficacy of antiviral treatment on post-hepatectomy survival for advanced stage hepatitis B virus\u2009\u2013\u2009related hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2018.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}